Mr. William Fink R.Ph.
President, Managed Care Pharmacy Consultants, Inc
Member of the Healthcare Council
Council Member Biography
William Fink, RPh, is the President of Managed Care Pharmacy Consultants in Tucson, Arizona. He has been active in managed care pharmacy for over 25 years. Mr. Fink's expertise includes managing pharmacy and clinical programs for HMOs (including Medicare and Medicaid) and self insured employer groups. He evaluates new biotech and orphan drug pharmaceuticals for formulary inclusion. Mr. Fink developed the Rx Accord software program to provide patient pharmacy and laboratory data to hospital emergency rooms and in-patient facilities. In the field of Health Information Exchange (HIE), he has contracted with the state of Arizona to develop the ability of physicians, hospital EDs, and urgent care centers to access patient pharmacy and laboratory data through a secure website. Mr. Fink also has a wide knowledge of the profit structure, price trends, and other trends that will drive PBM performance over the next few years. (This is me - Update Profile)
Employment History
- 1992 - Unspecified
- President, Managed Care Pharmacy Consultants, Inc
GLG NewsSM Analyses by William Fink
GLG News is now G+ Insights
-
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
-
"Health Care Laws by Any Name Will Not Work"
June 15, 2011
You can name the health care laws "ObamaCare", "Palin Care", "Trump Care", "Huckabee Care", or any "Care" you want, but they will not work, because it is not the laws that are messed up it is the public that is messed up.
-
May 11, 2011
There are many articles written by attorneys explaining how they can write contracts with the PBMs in order to save their clients a great deal of money.
-
Does the Teva Cephalon Deal have an unknown problem?
May 3, 2011
Teva to acquire Cephalon in 6.8 Billion Transaction | www.glgroup.com
Teva is embarking on a new and exciting future for its "Branded Business" Teva wants to obtain the "Dollars" from PROVIGIL. Provigil is a very expensive product for Narcolepsy. The price on this product was increased over 40% (approx) a few months ago. I am a clinical pharmacist , and manage pharmacy programs for HMOs and Self Insured Employer Groups. The time is coming when payors will not be able to afford medications with out a large increase in Employees out of pocket expenses.
-
August 28, 2008
Dr. Mark Yergin testifies to Congress | www.nytimes.com
Doctors must be educated on the correct use of Methadone if unnecessary deaths are to be avoided.
-
Trends for Chronic Kidney Disease (CKD)
June 26, 2008
Resource Article: “Chronic Kidney Disease Prevalence Increases, Awareness Remains Low,” Drug Benefit Trends (vol. 20, no. 5, May 2008) | jama.ama-assn.org
There will be an increased use of costly diaylsis, especially among those people 70 years or older. One would think that there would be a greater awareness of a disease consting $31 billion dollars a year. However, this does not seem to be the case.
GLG Study Groups with William Fink(?)
| Study Group Name | No. Members |
|---|---|
| Generic Drug Economic Experts | 890 |
| Economic Experts on Managed Care | 804 |
| Managed Care Experts | 733 |
| Medicare Experts | 570 |
| Physicians who Treat Acne (US) | 364 |
GLG Live Meetings with William Fink(?)
William Fink has not participated in any GLG Live Meetings.
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.